10 Works

Additional file 3 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Presentation published via figshare
Additional file 3: Supplementary Figure 3. Kaplan-Meier estimates of DFS (A) and OS (B) according to EVI1 expression in the non-pCR subgroup. Abbreviations:pCR, pathological complete response; DFS, disease-free survival; OS, overallsurvival.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21275639.v1 Cite

Additional file 1 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Presentation published via figshare
Additional file 1: Supplementary Figure 1. Flow diagram of patients included in the analysis set from GeparTrio study.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21275633.v1 Cite

Additional file 1 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Presentation published via figshare
Additional file 1: Supplementary Figure 1. Flow diagram of patients included in the analysis set from GeparTrio study.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21275633 Cite

Additional file 2 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Presentation published via figshare
Additional file 2: Supplementary Figure 2. Distribution of EVI1 continuous expression in breast cancer: A: Histogram of EVI1 continuous expression in the entire cohort (N=993); B: Boxplots of EVI1 continuous expression within breast cancer subtypes. Note, 882/993 patients with available BC subtype information were included in this analysis. Horizontal bold lines present EVI1 median values of 116.65 in HR+/HER2-, 98.67 in HR+/HER2+, 114.77in HR-/HER2+, and 115.64 in TNBC; boxes present the interquartile range between first...
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21275636.v1 Cite

Additional file 1 of Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

Damian T. Rieke, Till de Bortoli, Peter Horak, Mario Lamping, Manuela Benary, Ivan Jelas, Gina Rüter, Johannes Berger, Marit Zettwitz, Niklas Kagelmann, Andreas Kind, Falk Fabian, Dieter Beule, Hanno Glimm, Benedikt Brors, Albrecht Stenzinger, Stefan Fröhling & Ulrich Keilholz
Presentation published via figshare
Additional file 1: Figure S1. Shows the respective molecular tumor board workflows of Heidelberg (HDB) and Berlin (BLN). Corresponding steps are indicated by their respective colors.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21385901.v1 Cite

Additional file 3 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Presentation published via figshare
Additional file 3: Supplementary Figure 3. Kaplan-Meier estimates of DFS (A) and OS (B) according to EVI1 expression in the non-pCR subgroup. Abbreviations:pCR, pathological complete response; DFS, disease-free survival; OS, overallsurvival.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21275639 Cite

Additional file 1 of Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models

Kennedy Mwai, Irene Nkumama, Amos Thairu, James Mburu, Dennis Odera, Rinter Kimathi, Lydia Nyamako, James Tuju, Samson Kinyanjui, Eustasius Musenge & Faith Osier
Presentation published via figshare
Additional file 1: Table S1. Parasites/µL cut off using Logistic regression. Fig S1. Distribution of predicted probabilities. Fig S2. Comparison of probabilities for Bayesian and Logistic, Junju 2008. Table S2. Anova test for Figure 2B. Fig S3. Comparison of probability of febrile and non-febrile. Fig S4. Predicted probabilities over age groups. Fig S5. Sensitivity and specificity of the different years. Fig S6. Posterior estimates of AF.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21546664 Cite

Additional file 2 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Presentation published via figshare
Additional file 2: Supplementary Figure 2. Distribution of EVI1 continuous expression in breast cancer: A: Histogram of EVI1 continuous expression in the entire cohort (N=993); B: Boxplots of EVI1 continuous expression within breast cancer subtypes. Note, 882/993 patients with available BC subtype information were included in this analysis. Horizontal bold lines present EVI1 median values of 116.65 in HR+/HER2-, 98.67 in HR+/HER2+, 114.77in HR-/HER2+, and 115.64 in TNBC; boxes present the interquartile range between first...
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21275636 Cite

Additional file 1 of Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models

Kennedy Mwai, Irene Nkumama, Amos Thairu, James Mburu, Dennis Odera, Rinter Kimathi, Lydia Nyamako, James Tuju, Samson Kinyanjui, Eustasius Musenge & Faith Osier
Presentation published via figshare
Additional file 1: Table S1. Parasites/µL cut off using Logistic regression. Fig S1. Distribution of predicted probabilities. Fig S2. Comparison of probabilities for Bayesian and Logistic, Junju 2008. Table S2. Anova test for Figure 2B. Fig S3. Comparison of probability of febrile and non-febrile. Fig S4. Predicted probabilities over age groups. Fig S5. Sensitivity and specificity of the different years. Fig S6. Posterior estimates of AF.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21546664.v1 Cite

Additional file 1 of Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

Damian T. Rieke, Till de Bortoli, Peter Horak, Mario Lamping, Manuela Benary, Ivan Jelas, Gina Rüter, Johannes Berger, Marit Zettwitz, Niklas Kagelmann, Andreas Kind, Falk Fabian, Dieter Beule, Hanno Glimm, Benedikt Brors, Albrecht Stenzinger, Stefan Fröhling & Ulrich Keilholz
Presentation published via figshare
Additional file 1: Figure S1. Shows the respective molecular tumor board workflows of Heidelberg (HDB) and Berlin (BLN). Corresponding steps are indicated by their respective colors.
No citations were reported. No usage information was reported.
https://doi.org/10.6084/m9.figshare.21385901 Cite

Registration Year

  • 2022
    10

Resource Types

  • Audiovisual
    10

Affiliations

  • University Hospital Heidelberg
    10
  • Charité - University Medicine Berlin
    8
  • Heidelberg University
    8
  • German Cancer Research Center
    8
  • Universitätsklinikum Erlangen
    6
  • Sankt Gertrauden Krankenhaus
    6
  • Philipps University of Marburg
    6
  • University Hospital Schleswig-Holstein
    6
  • University Medical Center Hamburg-Eppendorf
    6
  • Universitätsklinikum Aachen
    6

About DataCite

Services

Resources

Community